A 2019 update : approach to asthma management in adults

Asthma is a chronic inflammatory disease that causes hyper-responsiveness of the bronchial tree, with reversible airflow obstruction. The condition places a significant burden on our healthcare system. Chronic asthma can cause remodelling of the airway. Patients suffering from asthma should be aware...

Full description

Saved in:
Bibliographic Details
Published in:South Africa Pharmaceutical Journal 2019-09, Vol.86 (4), p.38-44
Main Authors: Mogale, K., Schellack, N., Esterhuizen, A., Mokwele, N., Truter, A., Ntuli, P.N.
Format: Article
Language:English
Subjects:
Asthma
Bronchodilator
Bronchodilators
Inhaled corticosteroid
LABA
Peak expiratory flow
SABA
Spirometry
β-agonist
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Asthma is a chronic inflammatory disease that causes hyper-responsiveness of the bronchial tree, with reversible airflow obstruction. The condition places a significant burden on our healthcare system. Chronic asthma can cause remodelling of the airway. Patients suffering from asthma should be aware of the signs and symptoms thereof, as well as the factors that can precipitate an asthmatic attack. Asthma is mostly classified as either acute or chronic; the diagnosis of asthma is based on identifying both a characteristic pattern of respiratory symptoms and variable expiratory airflow limitation. Treatment is based on how the patient presents and includes bronchodilators, inhaled corticosteroids and mast cell stabilisers. This article provides an overview on the diagnosis, characterisation and treatment of asthma.
ISSN:2221-5875
2220-1017